H.C. Wainwright lowered the firm’s price target on Neurocrine (NBIX) to $185 from $190 and keeps a Buy rating on the shares. FY25 Ingrezza ...

H.C. Wainwright initiated coverage of Vertical Aerospace (EVTL) with a Buy rating and $12 price target The company specializes in designing ...

Adicet Bio (NASDAQ:ACET – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. A number of other ...

H.C. Wainwright analyst Mike Colonnese reiterated the Buy rating on CleanSpark, Inc. (NASDAQ:CLSK), with a price forecast of ...

H.C. Wainwright analyst Mitchell S. Kapoor revised the price target on Alumis Inc (NASDAQ:ALMS) to $19.00, down from the previous target of $26.00, while retaining a Buy rating for the company's ...

Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...

Equities researchers at StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock ...

Would you like to be notified of the latest news and updates on the stock market?

Fishman announced that ORLYNVAH benefits from 10 years of market exclusivity under the GAIN Act, extending to October 2034, and additional patent protection into 2039. He highlighted ongoing strategic ...